Insiders · Profile

Hecht Beth

See Remarks at Xeris Biopharma. Filing since 20 Mar 2025. CIK 0001652410

Company

Date

Role

Action

Shares

Amount

Of holding

XERS Xeris Biopharma Holdings, Inc.

1 Oct 2026

See Remarks

Sold on a plan

16,666

$156.79K

1.5%

XERS Xeris Biopharma Holdings, Inc.

1 Sep 2026

See Remarks

Sold on a plan

16,666

$141.43K

1.5%

XERS Xeris Biopharma Holdings, Inc.

3 Aug 2026

See Remarks

Sold on a plan

16,666

$133.55K

1.4%

XERS Xeris Biopharma Holdings, Inc.

1 Jul 2026

See Remarks

Sold on a plan

16,666

$133.86K

1.4%

XERS Xeris Biopharma Holdings, Inc.

1 Jun 2026

See Remarks

Sold on a plan

16,667

$100.98K

1.4%

XERS Xeris Biopharma Holdings, Inc.

1 May 2026

See Remarks

Sold on a plan

16,667

$103.81K

1.4%

XERS Xeris Biopharma Holdings, Inc.

1 Apr 2026

See Remarks

Sold on a plan

16,667

$99.86K

1.4%

XERS Xeris Biopharma Holdings, Inc.

2 Mar 2026

See Remarks

Sold on a plan

16,667

$104.09K

1.3%

XERS Xeris Biopharma Holdings, Inc.

2 Feb 2026

See Remarks

Sold at will

16,667

$124.15K

1.3%

XERS Xeris Biopharma Holdings, Inc.

2 Jan 2026

See Remarks

Sold on a plan

16,667

$123.78K

1.3%

XERS Xeris Biopharma Holdings, Inc.

1 Dec 2025

See Remarks

Sold on a plan

16,667

$116.78K

1.2%

XERS Xeris Biopharma Holdings, Inc.

11 Nov 2025

See Remarks

Sold on a plan

16,667

$123.30K

1.2%

XERS Xeris Biopharma Holdings, Inc.

20 Mar 2025

See Remarks

Sold at will

40,000

$217.24K

2.9%

13 decisions on file.